Central Nervous System Stimulant [EPC]

Central Nervous System Stimulant [EPC] was reported 87385 times

Drugs of the Central Nervous System Stimulant [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 GRIP STRENGTH 139 0.6070
1 ADHESIVE TAPE USE 167 0.4349
2 DEEP VEIN THROMBOSIS POSTOPERATIVE 752 0.3754
3 C-REACTIVE PROTEIN 296 0.3193
4 SWOLLEN JOINT COUNT 78 0.3120
5 LUPUS VULGARIS 387 0.3071
6 ADULTERATED PRODUCT 56 0.2800
7 MEDICATION OVERUSE HEADACHE 236 0.2757
8 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 162 0.2425
9 SWOLLEN JOINT COUNT INCREASED 672 0.2105
10 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 410 0.1977
11 DISTURBANCE IN SOCIAL BEHAVIOUR 462 0.1959
12 PULMONARY MALFORMATION 65 0.1852
13 X-RAY ABNORMAL 317 0.1771
14 RHEUMATIC FEVER 753 0.1688
15 FACET JOINT SYNDROME 523 0.1605
16 DUODENAL ULCER PERFORATION 1115 0.1498
17 DISLOCATION OF VERTEBRA 333 0.1459
18 RHEUMATOID FACTOR POSITIVE 826 0.1429
19 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 1018 0.1419
20 PRODUCT INEFFECTIVE 103 0.1310
21 PORPHYRIA ACUTE 188 0.1310
22 EDUCATIONAL PROBLEM 214 0.1286
23 PERIPHERAL VENOUS DISEASE 515 0.1260
24 RETINITIS 217 0.1255
25 SEDATION COMPLICATION 315 0.1233
26 C-REACTIVE PROTEIN ABNORMAL 763 0.1188
27 MUSCLE INJURY 967 0.1166
28 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 3369 0.1149
29 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 740 0.1138
30 HELICOBACTER INFECTION 1142 0.1110
31 FOLLICULITIS 1078 0.1027
32 CHOREOATHETOSIS 63 0.0928
33 PEMPHIGUS 1144 0.0914
34 HAND DEFORMITY 1168 0.0890
35 AUTOIMMUNE DISORDER 808 0.0828
36 CATAPLEXY 117 0.0826
37 MULTIPLE DRUG THERAPY 62 0.0822
38 DRUG EFFECT VARIABLE 87 0.0768
39 DRUG TOLERANCE DECREASED 214 0.0761
40 BONE EROSION 266 0.0751
41 CREATININE RENAL CLEARANCE DECREASED 294 0.0734
42 LIP DRY 667 0.0734
43 PERICARDITIS 1188 0.0706
44 APPLICATION SITE ERYTHEMA 1850 0.0705
45 SCHIZOAFFECTIVE DISORDER 124 0.0695
46 INCORRECT STORAGE OF DRUG 118 0.0682
47 DRUG ADMINISTRATION ERROR 2068 0.0673
48 APPLICATION SITE URTICARIA 148 0.0659
49 DRUG ADMINISTERED AT INAPPROPRIATE SITE 695 0.0658
50 CORONARY ARTERY DISSECTION 56 0.0652
51 MATERNAL EXPOSURE TIMING UNSPECIFIED 239 0.0636
52 BREAST CANCER STAGE III 403 0.0622
53 BURSITIS 731 0.0602
54 APPLICATION SITE IRRITATION 746 0.0599
55 SYNOVITIS 1074 0.0595
56 DRUG PRESCRIBING ERROR 1115 0.0580
57 PRE-EXISTING CONDITION IMPROVED 352 0.0563
58 ULCER HAEMORRHAGE 368 0.0543
59 WRONG TECHNIQUE IN DRUG USAGE PROCESS 1896 0.0521
60 GLOSSODYNIA 1162 0.0518
61 IMPULSIVE BEHAVIOUR 190 0.0506
62 TIC 276 0.0506
63 JOINT RANGE OF MOTION DECREASED 678 0.0505
64 GRIP STRENGTH DECREASED 444 0.0504
65 IRRITABLE BOWEL SYNDROME 1079 0.0503
66 LIVE BIRTH 419 0.0500
67 APPLICATION SITE EROSION 64 0.0497
68 FIBROMYALGIA 1204 0.0495
69 INCORRECT DRUG ADMINISTRATION DURATION 1387 0.0493
70 SCIATICA 760 0.0476
71 SUBSTANCE USE DISORDER 145 0.0455
72 NARCOLEPSY 84 0.0445
73 PRODUCT QUALITY ISSUE 5935 0.0437
74 OBSTRUCTIVE SLEEP APNOEA SYNDROME 63 0.0432
75 PRESCRIBED OVERDOSE 829 0.0428
76 LOWER LIMB FRACTURE 809 0.0421
77 APPLICATION SITE SWELLING 209 0.0419
78 PRODUCT ADMINISTRATION INTERRUPTED 328 0.0417
79 ATTENTION DEFICIT HYPERACTIVITY DISORDER 175 0.0415
80 WOUND INFECTION 454 0.0414
81 PSYCHOMOTOR HYPERACTIVITY 679 0.0409
82 HYPERCHOLESTEROLAEMIA 394 0.0408
83 LOGORRHOEA 143 0.0405
84 LIVER INJURY 980 0.0399
85 APPLICATION SITE PRURITUS 905 0.0398
86 REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME 78 0.0395
87 NO ADVERSE EVENT 7084 0.0391
88 OESOPHAGEAL SPASM 72 0.0390
89 THERAPEUTIC PRODUCT INEFFECTIVE 149 0.0385
90 WOUND 1074 0.0384
91 OBESITY 609 0.0382
92 EYE INJURY 115 0.0378
93 HYPERKINESIA 79 0.0372
94 THERAPEUTIC PRODUCT EFFECT VARIABLE 144 0.0371
95 SUBSTANCE ABUSE 292 0.0358
96 ENURESIS 142 0.0351
97 DRUG EFFECT INCREASED 111 0.0351
98 SUBSTANCE USE 54 0.0346
99 APPLICATION SITE DISCOLOURATION 138 0.0339
100 SYSTEMIC LUPUS ERYTHEMATOSUS 1198 0.0337
101 EXOSTOSIS 306 0.0335
102 IMPAIRED HEALING 1057 0.0322
103 WALKING AID USER 212 0.0321
104 DRUG EFFECT DELAYED 143 0.0315
105 TYPE 2 DIABETES MELLITUS 1052 0.0312
106 CONTRAINDICATED PRODUCT ADMINISTERED 922 0.0304
107 DRUG ABUSE 2530 0.0304
108 APPLICATION SITE DRYNESS 103 0.0303
109 DRUG DIVERSION 187 0.0302
110 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 66 0.0295
111 ACCIDENTAL DEATH 54 0.0290
112 BLOOD CALCIUM DECREASED 322 0.0286
113 ACCIDENTAL EXPOSURE 119 0.0286
114 APPLICATION SITE RASH 390 0.0283
115 BLEPHAROSPASM 177 0.0281
116 DRUG TOLERANCE 142 0.0280
117 ALCOHOL POISONING 75 0.0280
118 PRODUCT ADHESION ISSUE 997 0.0279
119 PULMONARY FIBROSIS 532 0.0277
120 DISTURBANCE IN ATTENTION 1447 0.0268
121 BLOOD CHOLESTEROL INCREASED 1233 0.0264
122 PSORIATIC ARTHROPATHY 1069 0.0263
123 NIGHT SWEATS 847 0.0263
124 APPLICATION SITE PAIN 577 0.0262
125 ROAD TRAFFIC ACCIDENT 1087 0.0260
126 LOWER RESPIRATORY TRACT INFECTION 1162 0.0255
127 MIGRAINE 2437 0.0255
128 TORTICOLLIS 54 0.0254
129 TOXICITY TO VARIOUS AGENTS 4232 0.0251
130 APPLICATION SITE SCAB 54 0.0250
131 FOOT DEFORMITY 277 0.0250
132 LUPUS-LIKE SYNDROME 226 0.0249
133 SNORING 94 0.0248
134 SLEEP APNOEA SYNDROME 472 0.0247
135 POISONING 307 0.0244
136 ARTHROPATHY 1329 0.0239
137 GAIT INABILITY 797 0.0238
138 ONYCHOMADESIS 100 0.0238
139 SUSPECTED SUICIDE 111 0.0237
140 SOMNAMBULISM 155 0.0236
141 PRODUCT ADMINISTRATION ERROR 475 0.0235
142 SEROTONIN SYNDROME 438 0.0228
143 OSTEOARTHRITIS 966 0.0228
144 EXPOSURE VIA INGESTION 57 0.0226
145 SEDATION 591 0.0225
146 KOUNIS SYNDROME 51 0.0224
147 HIP ARTHROPLASTY 343 0.0224
148 APPLICATION SITE BURN 110 0.0223
149 JOINT DISLOCATION 231 0.0218
150 HYPERREFLEXIA 76 0.0218
151 PREGNANCY 434 0.0217
152 DISCOMFORT 1319 0.0216
153 BLISTER 1194 0.0212
154 AFFECT LABILITY 204 0.0212
155 ONYCHOMYCOSIS 93 0.0212
156 MOBILITY DECREASED 1521 0.0211
157 THERAPEUTIC PRODUCT EFFECT DECREASED 929 0.0207
158 PRODUCT USE IN UNAPPROVED INDICATION 5139 0.0207
159 STOMATITIS 1241 0.0204
160 MATERNAL EXPOSURE DURING BREAST FEEDING 83 0.0204
161 BRAIN OEDEMA 258 0.0204
162 ORTHOSTATIC HYPOTENSION 352 0.0202
163 BREAST CANCER STAGE II 168 0.0202
164 MYDRIASIS 258 0.0201
165 INFUSION RELATED REACTION 1332 0.0201
166 DEVICE ADHESION ISSUE 308 0.0201
167 HEPATIC ENZYME INCREASED 1363 0.0200
168 DRUG USE DISORDER 168 0.0200
169 FEELING JITTERY 378 0.0198
170 RED BLOOD CELL SEDIMENTATION RATE INCREASED 219 0.0198
171 COMPLETED SUICIDE 1643 0.0197
172 OEDEMA 1068 0.0197
173 AGGRESSION 983 0.0196
174 MIGRAINE WITH AURA 53 0.0195
175 TRISMUS 100 0.0193
176 GROWTH RETARDATION 57 0.0193
177 DRUG EFFECT LESS THAN EXPECTED 285 0.0192
178 ABNORMAL BEHAVIOUR 762 0.0192
179 THERAPEUTIC RESPONSE UNEXPECTED 862 0.0192
180 APPLICATION SITE VESICLES 124 0.0191
181 HANGOVER 67 0.0190
182 DRUG SCREEN POSITIVE 149 0.0188
183 INITIAL INSOMNIA 193 0.0188
184 THERAPEUTIC RESPONSE CHANGED 119 0.0188
185 BRUXISM 101 0.0187
186 INJURY 1308 0.0186
187 HYPOPNOEA 63 0.0181
188 APPLICATION SITE EXFOLIATION 74 0.0179
189 CHOLECYSTITIS CHRONIC 119 0.0178
190 HOMICIDAL IDEATION 72 0.0177
191 LIVER DISORDER 786 0.0177
192 PRE-ECLAMPSIA 84 0.0177
193 RENAL FUNCTION TEST ABNORMAL 82 0.0176
194 ARTERIOSCLEROSIS CORONARY ARTERY 117 0.0176
195 THERAPY NON-RESPONDER 789 0.0175
196 NAIL DISORDER 153 0.0175
197 DELIRIUM 604 0.0174
198 EXPIRED DRUG ADMINISTERED 86 0.0174
199 TACHYPHRENIA 60 0.0173
200 EXPOSURE TO TOXIC AGENT 55 0.0172
201 PRESCRIBED UNDERDOSE 343 0.0172
202 SLEEP DISORDER 1210 0.0171
203 INFUSION SITE PRURITUS 54 0.0171
204 EXPOSURE VIA BREAST MILK 68 0.0171
205 RESPIRATORY DEPRESSION 209 0.0170
206 SINUSITIS 1737 0.0169
207 EAR PAIN 326 0.0168
208 PRODUCT SUBSTITUTION ISSUE 965 0.0167
209 BACK INJURY 182 0.0167
210 OESOPHAGEAL PAIN 66 0.0167
211 MUSCULOSKELETAL PAIN 872 0.0166
212 NORMAL NEWBORN 90 0.0165
213 SPONDYLITIS 60 0.0165
214 KNEE ARTHROPLASTY 345 0.0164
215 HEPATIC CIRRHOSIS 307 0.0163
216 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 280 0.0163
217 POST-TRAUMATIC STRESS DISORDER 108 0.0161
218 WHEEZING 951 0.0160
219 ARTERIOSPASM CORONARY 63 0.0157
220 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 80 0.0156
221 MAJOR DEPRESSION 114 0.0156
222 CARDIAC VALVE DISEASE 89 0.0156
223 THERAPEUTIC PRODUCT EFFECT DELAYED 71 0.0155
224 PRODUCT LABEL CONFUSION 90 0.0154
225 LUNG DISORDER 755 0.0154
226 DEPRESSED LEVEL OF CONSCIOUSNESS 603 0.0152
227 BEHAVIOUR DISORDER 82 0.0151
228 SWELLING 1417 0.0151
229 AGITATION 1100 0.0150
230 EAR INFECTION 396 0.0149
231 ILL-DEFINED DISORDER 901 0.0148
232 GASTROINTESTINAL DISORDER 1328 0.0148
233 MUSCULOSKELETAL STIFFNESS 1284 0.0146
234 SPINAL FUSION SURGERY 59 0.0145
235 AUTISM SPECTRUM DISORDER 80 0.0145
236 MATERNAL EXPOSURE DURING PREGNANCY 1286 0.0144
237 CONTUSION 1385 0.0144
238 CARDIO-RESPIRATORY ARREST 601 0.0144
239 DRY MOUTH 1166 0.0144
240 RESPIRATORY ARREST 396 0.0144
241 SEASONAL ALLERGY 203 0.0143
242 OBSESSIVE-COMPULSIVE DISORDER 115 0.0143
243 DRUG LEVEL INCREASED 236 0.0142
244 IRRITABILITY 857 0.0142
245 DYSTONIA 276 0.0142
246 PARANOIA 245 0.0142
247 APATHY 205 0.0140
248 INTENTIONAL PRODUCT USE ISSUE 1221 0.0139
249 DISABILITY 275 0.0139
250 DRUG INTOLERANCE 1342 0.0139
251 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 235 0.0138
252 ANGER 466 0.0138
253 EUPHORIC MOOD 141 0.0138
254 COGNITIVE DISORDER 640 0.0137
255 HYPERACUSIS 51 0.0137
256 CONCUSSION 106 0.0137
257 CONGENITAL ANOMALY 105 0.0136
258 RESPIRATORY DISORDER 405 0.0135
259 SCREAMING 86 0.0135
260 SUICIDAL BEHAVIOUR 56 0.0134
261 FEELING DRUNK 100 0.0134
262 ABDOMINAL DISCOMFORT 2251 0.0134
263 INFUSION SITE SWELLING 84 0.0133
264 FINGER DEFORMITY 64 0.0132
265 INTENTIONAL OVERDOSE 846 0.0132
266 HYPERPHAGIA 52 0.0130
267 COELIAC DISEASE 127 0.0129
268 WEIGHT FLUCTUATION 135 0.0129
269 MUSCLE SPASTICITY 158 0.0128
270 BIPOLAR DISORDER 139 0.0128
271 DRUG ABUSER 78 0.0127
272 CONFUSIONAL STATE 2051 0.0127
273 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 78 0.0126
274 EXPOSURE DURING PREGNANCY 781 0.0126
275 BREAST MASS 84 0.0125
276 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 229 0.0125
277 INFLAMMATION 642 0.0124
278 LYMPHOEDEMA 86 0.0124
279 INTRACRANIAL PRESSURE INCREASED 69 0.0124
280 IMPAIRED DRIVING ABILITY 140 0.0123
281 AMNESIA 800 0.0123
282 SELF-INJURIOUS IDEATION 51 0.0121
283 DISSOCIATION 93 0.0121
284 HALLUCINATIONS, MIXED 51 0.0121
285 TREATMENT FAILURE 1004 0.0121
286 DECREASED INTEREST 71 0.0120
287 ANXIETY 3415 0.0120
288 RHEUMATOID ARTHRITIS 1361 0.0120
289 PANIC REACTION 86 0.0119
290 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 81 0.0119
291 SUICIDAL IDEATION 1086 0.0119
292 SINUS TACHYCARDIA 168 0.0118
293 UNRESPONSIVE TO STIMULI 305 0.0118
294 VITAMIN D DECREASED 101 0.0118
295 BRAIN INJURY 118 0.0118
296 POOR QUALITY SLEEP 253 0.0117
297 JOINT SWELLING 1418 0.0117
298 LIVER FUNCTION TEST INCREASED 252 0.0117
299 MEDICATION ERROR 652 0.0117
300 MIOSIS 94 0.0117
301 INSOMNIA 3119 0.0117
302 AFFECTIVE DISORDER 92 0.0117
303 GASTRIC ULCER 222 0.0117
304 TENSION HEADACHE 50 0.0116
305 BODY TEMPERATURE INCREASED 237 0.0116
306 DERMATITIS CONTACT 132 0.0116
307 MANIA 190 0.0115
308 ABDOMINAL PAIN UPPER 2377 0.0115
309 SUICIDE ATTEMPT 700 0.0115
310 GESTATIONAL DIABETES 55 0.0115
311 PSYCHOTIC DISORDER 340 0.0115
312 CRYING 415 0.0114
313 MATERNAL EXPOSURE BEFORE PREGNANCY 78 0.0114
314 HYPOAESTHESIA 1707 0.0114
315 RASH VESICULAR 55 0.0114
316 ELECTROCARDIOGRAM QT PROLONGED 409 0.0114
317 PRODUCT FORMULATION ISSUE 75 0.0114
318 TACHYCARDIA 1004 0.0113
319 RESTLESSNESS 413 0.0113
320 ASTHMA 1274 0.0113
321 NYSTAGMUS 59 0.0111
322 PANIC ATTACK 404 0.0111
323 VITAMIN D DEFICIENCY 108 0.0111
324 DRUG DOSE OMISSION 1826 0.0110
325 HYPERTENSION 2339 0.0110
326 NEPHROGENIC ANAEMIA 51 0.0110
327 DYSPEPSIA 1081 0.0110
328 DYSKINESIA 446 0.0110
329 GENERAL PHYSICAL HEALTH DETERIORATION 1268 0.0109
330 INFUSION SITE ERYTHEMA 92 0.0109
331 DECREASED APPETITE 2530 0.0109
332 FOOD ALLERGY 84 0.0109
333 INTENTIONAL SELF-INJURY 218 0.0108
334 APNOEA 84 0.0108
335 RESTLESS LEGS SYNDROME 196 0.0108
336 ULCER 171 0.0107
337 DEPRESSION 2438 0.0107
338 SPINAL OSTEOARTHRITIS 94 0.0107
339 WITHDRAWAL SYNDROME 449 0.0107
340 STOMACH DISCOMFORT 55 0.0106
341 CARDIAC MURMUR 92 0.0106
342 INFUSION SITE PAIN 137 0.0106
343 FREQUENT BOWEL MOVEMENTS 287 0.0106
344 JOINT STIFFNESS 278 0.0106
345 SKIN ABRASION 50 0.0106
346 C-REACTIVE PROTEIN INCREASED 384 0.0105
347 INTENTIONAL PRODUCT MISUSE 923 0.0105
348 MULTIPLE DRUG OVERDOSE 52 0.0105
349 BLADDER DISORDER 104 0.0105
350 OVERWEIGHT 56 0.0104
351 HALLUCINATION, VISUAL 220 0.0104
352 INTERVERTEBRAL DISC DEGENERATION 96 0.0104
353 SOCIAL AVOIDANT BEHAVIOUR 60 0.0104
354 OFF LABEL USE 9069 0.0103
355 PAROSMIA 78 0.0103
356 OVERDOSE 2229 0.0103
357 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 74 0.0103
358 INCREASED APPETITE 197 0.0103
359 ANAL INCONTINENCE 92 0.0102
360 EMOTIONAL DISORDER 315 0.0102
361 HALLUCINATION, AUDITORY 161 0.0101
362 HUNGER 141 0.0101
363 APPETITE DISORDER 67 0.0101
364 APPLICATION SITE REACTION 71 0.0101
365 HYPERTHERMIA 77 0.0101
366 FOETAL DEATH 52 0.0100
367 POISONING DELIBERATE 95 0.0100
368 CHEST PAIN 1855 0.0100
369 PULMONARY CONGESTION 132 0.0100
370 URTICARIA 1673 0.0100
371 HYPERSENSITIVITY 1846 0.0099
372 EYE MOVEMENT DISORDER 67 0.0098
373 DEPRESSED MOOD 517 0.0098
374 DRUG INTERACTION 1549 0.0098
375 ACCIDENTAL OVERDOSE 356 0.0097
376 MOOD SWINGS 310 0.0097
377 MULTIPLE ALLERGIES 76 0.0097
378 SOMNOLENCE 1951 0.0097
379 BLOOD LACTIC ACID INCREASED 51 0.0097
380 PRODUCT AVAILABILITY ISSUE 220 0.0097
381 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 530 0.0096
382 HYPERTRANSAMINASAEMIA 67 0.0096
383 PHOTOPHOBIA 181 0.0096
384 MEMORY IMPAIRMENT 1319 0.0096
385 NASOPHARYNGITIS 1767 0.0096
386 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 459 0.0095
387 ENERGY INCREASED 56 0.0095
388 PERIPHERAL SWELLING 1459 0.0095
389 MOOD ALTERED 258 0.0095
390 INTERVERTEBRAL DISC PROTRUSION 206 0.0094
391 DELUSION 146 0.0094
392 GASTRIC ULCER HAEMORRHAGE 52 0.0094
393 ALOPECIA 1836 0.0093
394 STREPTOCOCCAL INFECTION 52 0.0093
395 WEIGHT INCREASED 2078 0.0093
396 BALANCE DISORDER 797 0.0092
397 SCOLIOSIS 57 0.0092
398 MUSCLE TWITCHING 212 0.0092
399 ECCHYMOSIS 63 0.0092
400 GASTROOESOPHAGEAL REFLUX DISEASE 738 0.0092
401 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 651 0.0091
402 HEADACHE 5716 0.0091
403 OSTEOPOROSIS 375 0.0091
404 STRESS CARDIOMYOPATHY 53 0.0091
405 CONDITION AGGRAVATED 2751 0.0090
406 GINGIVAL PAIN 72 0.0090
407 EMPHYSEMA 91 0.0090
408 INSURANCE ISSUE 137 0.0090
409 PRODUCT PHYSICAL ISSUE 180 0.0089
410 TENSION 54 0.0089
411 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1794 0.0088
412 INFECTION 1279 0.0088
413 RHINITIS 71 0.0088
414 HYPERVENTILATION 51 0.0088
415 MUSCLE TIGHTNESS 142 0.0088
416 REBOUND EFFECT 99 0.0088
417 IMPAIRED GASTRIC EMPTYING 119 0.0087
418 MYOSITIS 78 0.0087
419 FOOT FRACTURE 164 0.0086
420 NECK PAIN 483 0.0086
421 PULMONARY OEDEMA 386 0.0086
422 PERSONALITY CHANGE 80 0.0086
423 TACHYPNOEA 117 0.0086
424 CARDIAC ARREST 706 0.0085
425 DRUG EFFECT DECREASED 460 0.0085
426 INTENTIONAL DRUG MISUSE 178 0.0085
427 HEAD DISCOMFORT 150 0.0085
428 TINNITUS 388 0.0084
429 BACK DISORDER 137 0.0084
430 DRUG INEFFECTIVE 11102 0.0084
431 BRAIN FOG 132 0.0084
432 PARAESTHESIA 1325 0.0084
433 SINUS HEADACHE 50 0.0084
434 MIDDLE INSOMNIA 157 0.0084
435 PALPITATIONS 982 0.0084
436 RECTAL HAEMORRHAGE 360 0.0084
437 ACCIDENT 100 0.0084
438 NERVE INJURY 93 0.0084
439 EXPIRED PRODUCT ADMINISTERED 276 0.0083
440 ARTHRITIS 653 0.0083
441 METABOLIC ACIDOSIS 265 0.0083
442 URINARY INCONTINENCE 245 0.0083
443 BRADYPHRENIA 54 0.0083
444 SINUS DISORDER 163 0.0082
445 DENTAL CARIES 91 0.0082
446 MUSCULAR WEAKNESS 934 0.0082
447 FACIAL PAIN 73 0.0082
448 PRODUCT USE ISSUE 1534 0.0082
449 IMPAIRED QUALITY OF LIFE 117 0.0081
450 ACIDOSIS 62 0.0081
451 HYPERHIDROSIS 1045 0.0081
452 FORMICATION 56 0.0080
453 PERIPHERAL COLDNESS 110 0.0080
454 MUSCLE RIGIDITY 95 0.0079
455 MUSCLE SPASMS 1455 0.0079
456 FRUSTRATION TOLERANCE DECREASED 64 0.0079
457 NIGHTMARE 274 0.0079
458 COORDINATION ABNORMAL 110 0.0079
459 DEVICE BREAKAGE 320 0.0079
460 NERVOUSNESS 411 0.0079
461 MYOCARDITIS 90 0.0078
462 SLUGGISHNESS 80 0.0078
463 GENERALISED TONIC-CLONIC SEIZURE 129 0.0078
464 WHITE BLOOD CELL COUNT INCREASED 299 0.0078
465 FEELING ABNORMAL 1866 0.0078
466 CHOLELITHIASIS 254 0.0077
467 HYPERSOMNIA 222 0.0077
468 RETCHING 165 0.0077
469 HIATUS HERNIA 100 0.0077
470 LETHARGY 444 0.0077
471 SENSORY LOSS 62 0.0077
472 AKATHISIA 105 0.0077
473 NEURALGIA 187 0.0077
474 HEPATIC STEATOSIS 143 0.0077
475 MENTAL STATUS CHANGES 213 0.0077
476 SURGERY 449 0.0077
477 FEELING HOT 469 0.0076
478 THINKING ABNORMAL 142 0.0076
479 IRON DEFICIENCY ANAEMIA 70 0.0076
480 THERAPEUTIC RESPONSE DECREASED 459 0.0076
481 BRONCHIECTASIS 51 0.0076
482 IMPAIRED WORK ABILITY 161 0.0075
483 LABORATORY TEST ABNORMAL 222 0.0075
484 GASTRIC HAEMORRHAGE 86 0.0075
485 HEART RATE INCREASED 735 0.0074
486 TREATMENT NONCOMPLIANCE 405 0.0074
487 LIMB INJURY 201 0.0074
488 SALIVARY HYPERSECRETION 74 0.0074
489 MENTAL DISORDER 321 0.0074
490 ASPHYXIA 60 0.0073
491 TASTE DISORDER 149 0.0073
492 HALLUCINATION 553 0.0073
493 ADVERSE DRUG REACTION 659 0.0073
494 BLOOD IRON DECREASED 87 0.0073
495 ARTERIOSCLEROSIS 69 0.0073
496 DEVICE DIFFICULT TO USE 485 0.0073
497 HEPATOMEGALY 72 0.0073
498 SCHIZOPHRENIA 89 0.0073
499 NEPHROLITHIASIS 335 0.0073
500 COLITIS ULCERATIVE 326 0.0073
501 THIRST 130 0.0073
502 HYSTERECTOMY 63 0.0073
503 TOOTH FRACTURE 80 0.0072
504 UTERINE LEIOMYOMA 53 0.0072
505 VOMITING 3408 0.0072
506 TROPONIN INCREASED 55 0.0072
507 CIRCULATORY COLLAPSE 123 0.0072
508 EPILEPSY 220 0.0072
509 THERAPY CESSATION 369 0.0072
510 TRICUSPID VALVE INCOMPETENCE 57 0.0072
511 ANKLE FRACTURE 111 0.0072
512 GAIT DISTURBANCE 1368 0.0071
513 UPPER RESPIRATORY TRACT INFECTION 330 0.0071
514 UNDERDOSE 521 0.0071
515 BRONCHITIS 528 0.0071
516 CYANOSIS 112 0.0071
517 GASTRIC DISORDER 244 0.0071
518 LOSS OF CONSCIOUSNESS 908 0.0071
519 TREMOR 1175 0.0071
520 CARDIOMEGALY 87 0.0071
521 BLOOD MAGNESIUM DECREASED 61 0.0071
522 MOTOR DYSFUNCTION 72 0.0071
523 OEDEMA PERIPHERAL 861 0.0071
524 PELVIC FRACTURE 55 0.0071
525 WEIGHT DECREASED 1962 0.0070
526 ADRENAL INSUFFICIENCY 85 0.0070
527 SUPRAVENTRICULAR TACHYCARDIA 67 0.0070
528 STATUS EPILEPTICUS 79 0.0070
529 THERAPY PARTIAL RESPONDER 109 0.0070
530 MITRAL VALVE INCOMPETENCE 79 0.0070
531 DIZZINESS 3477 0.0070
532 SINUS CONGESTION 94 0.0070
533 IMMUNODEFICIENCY 103 0.0069
534 CYSTITIS 220 0.0069
535 ADVERSE EVENT 635 0.0069
536 DYSARTHRIA 259 0.0069
537 DECREASED ACTIVITY 74 0.0069
538 CARPAL TUNNEL SYNDROME 96 0.0068
539 NOCTURIA 83 0.0068
540 NERVE COMPRESSION 63 0.0068
541 INCONTINENCE 72 0.0068
542 DRUG DEPENDENCE 1095 0.0068
543 PSYCHIATRIC SYMPTOM 50 0.0068
544 ATAXIA 80 0.0067
545 DRUG-INDUCED LIVER INJURY 211 0.0067
546 NAUSEA 5285 0.0067
547 RENAL CYST 53 0.0067
548 THERAPEUTIC RESPONSE SHORTENED 221 0.0067
549 COMA 316 0.0066
550 ELECTROCARDIOGRAM ABNORMAL 52 0.0066
551 PRODUCT USE COMPLAINT 104 0.0066
552 SPINAL OPERATION 81 0.0066
553 PAIN 4039 0.0066
554 LIGAMENT SPRAIN 65 0.0066
555 ATRIAL SEPTAL DEFECT 55 0.0066
556 FATIGUE 5113 0.0066
557 CHOLECYSTECTOMY 75 0.0066
558 PANCREATITIS 347 0.0066
559 MENTAL IMPAIRMENT 159 0.0066
560 RHABDOMYOLYSIS 273 0.0065
561 ABDOMINAL PAIN 1520 0.0065
562 PARAESTHESIA ORAL 94 0.0065
563 HYPOTHYROIDISM 208 0.0065
564 WRIST FRACTURE 78 0.0065
565 OVARIAN CYST 65 0.0065
566 HYPOKINESIA 94 0.0065
567 HEAD INJURY 204 0.0064
568 GALLBLADDER DISORDER 115 0.0064
569 VERTIGO 392 0.0064
570 TENDERNESS 67 0.0064
571 RIB FRACTURE 132 0.0064
572 ALTERED STATE OF CONSCIOUSNESS 139 0.0064
573 JOINT INJURY 137 0.0064
574 NEUROLEPTIC MALIGNANT SYNDROME 76 0.0064
575 TEMPERATURE INTOLERANCE 66 0.0064
576 GRAND MAL CONVULSION 59 0.0064
577 HEMIPLEGIA 53 0.0064
578 GASTROENTERITIS VIRAL 115 0.0064
579 MUSCLE STRAIN 55 0.0064
580 SPINAL DISORDER 60 0.0063
581 FACIAL PARALYSIS 54 0.0063
582 INCREASED TENDENCY TO BRUISE 58 0.0063
583 MICTURITION URGENCY 72 0.0063
584 URINARY RETENTION 210 0.0063
585 MYOCLONUS 75 0.0063
586 PAIN IN JAW 178 0.0063
587 ARTHRALGIA 2607 0.0063
588 SCAR 107 0.0062
589 EAR DISCOMFORT 64 0.0062
590 THYROID DISORDER 96 0.0062
591 ACUTE MYOCARDIAL INFARCTION 183 0.0062
592 ECONOMIC PROBLEM 94 0.0062
593 PYREXIA 2142 0.0062
594 BLOOD PRESSURE INCREASED 943 0.0062
595 CONSTIPATION 1340 0.0061
596 FOETAL EXPOSURE DURING PREGNANCY 499 0.0061
597 INTENTIONAL DOSE OMISSION 175 0.0061
598 FEAR 165 0.0061
599 PHARYNGEAL SWELLING 60 0.0061
600 DRUG EFFECT INCOMPLETE 222 0.0061
601 FALL 2034 0.0061
602 SPEECH DISORDER 320 0.0061
603 BODY HEIGHT DECREASED 65 0.0061
604 ROTATOR CUFF SYNDROME 78 0.0061
605 CARDIOGENIC SHOCK 87 0.0061
606 HEREDITARY ANGIOEDEMA 65 0.0061
607 QUALITY OF LIFE DECREASED 81 0.0060
608 ASPIRATION 66 0.0060
609 ATELECTASIS 58 0.0060
610 ACUTE HEPATIC FAILURE 82 0.0060
611 ORAL HERPES 117 0.0060
612 VENTRICULAR EXTRASYSTOLES 62 0.0060
613 CHOKING 116 0.0059
614 VENTRICULAR FIBRILLATION 66 0.0059
615 ASTHENIA 2228 0.0059
616 ACTIVITIES OF DAILY LIVING IMPAIRED 117 0.0059
617 HAEMORRHOIDS 115 0.0059
618 DISORIENTATION 233 0.0059
619 RESPIRATORY TRACT INFECTION 153 0.0059
620 APHASIA 177 0.0059
621 HEMIPARESIS 99 0.0058
622 PRODUCT TASTE ABNORMAL 79 0.0058
623 UNEVALUABLE EVENT 440 0.0058
624 MALAISE 2550 0.0058
625 OSTEOPENIA 88 0.0058
626 SENSORY DISTURBANCE 93 0.0058
627 APPENDICITIS 54 0.0058
628 TOOTH INFECTION 76 0.0058
629 OROPHARYNGEAL DISCOMFORT 52 0.0058
630 TOOTHACHE 104 0.0057
631 FLUID RETENTION 292 0.0057
632 PAIN IN EXTREMITY 1691 0.0057
633 SEIZURE 661 0.0057
634 DIPLOPIA 148 0.0057
635 MUSCULOSKELETAL DISCOMFORT 98 0.0057
636 HYPERLIPIDAEMIA 68 0.0057
637 NEPHROPATHY 53 0.0057
638 DIZZINESS POSTURAL 55 0.0057
639 SUDDEN DEATH 60 0.0057
640 BACK PAIN 1307 0.0056
641 THROAT TIGHTNESS 152 0.0056
642 SKIN LACERATION 61 0.0056
643 CENTRAL NERVOUS SYSTEM LESION 77 0.0056
644 BLOOD POTASSIUM DECREASED 167 0.0055
645 HYPOKALAEMIA 256 0.0055
646 HYPOTHERMIA 56 0.0055
647 COAGULOPATHY 92 0.0055
648 ILLNESS 568 0.0055
649 GASTRITIS 145 0.0055
650 PRURITUS 2114 0.0055
651 RASH 2392 0.0055
652 INCORRECT PRODUCT STORAGE 72 0.0055
653 BEDRIDDEN 72 0.0055
654 VISION BLURRED 748 0.0054
655 DRUG TOXICITY 74 0.0054
656 ABNORMAL DREAMS 150 0.0054
657 ADVERSE REACTION 72 0.0054
658 DYSPNOEA 3062 0.0054
659 PNEUMONIA ASPIRATION 135 0.0054
660 LIMB DISCOMFORT 167 0.0054
661 BLOOD PRESSURE ABNORMAL 107 0.0054
662 ANHEDONIA 141 0.0054
663 MALNUTRITION 60 0.0054
664 MOVEMENT DISORDER 172 0.0054
665 CHRONIC KIDNEY DISEASE 406 0.0053
666 HYPOAESTHESIA ORAL 80 0.0053
667 HYPOTENSION 1064 0.0053
668 BLOOD CREATINE PHOSPHOKINASE INCREASED 152 0.0053
669 FEEDING DISORDER 107 0.0053
670 PHARYNGITIS STREPTOCOCCAL 57 0.0053
671 EATING DISORDER 112 0.0053
672 HEART RATE DECREASED 184 0.0052
673 ENCEPHALOPATHY 128 0.0052
674 DYSSTASIA 152 0.0052
675 SEXUAL DYSFUNCTION 61 0.0052
676 VISUAL IMPAIRMENT 642 0.0052
677 MULTIPLE SCLEROSIS RELAPSE 355 0.0052
678 SINUS BRADYCARDIA 50 0.0052
679 CYST 64 0.0052
680 LYMPHOCYTE COUNT DECREASED 91 0.0051
681 MULTIPLE SCLEROSIS 246 0.0051
682 SKIN HAEMORRHAGE 76 0.0051
683 PNEUMONIA 1655 0.0051
684 GASTROINTESTINAL PAIN 56 0.0051
685 ARRHYTHMIA 240 0.0051
686 KIDNEY INFECTION 99 0.0050
687 PULMONARY HYPERTENSION 105 0.0050
688 INCORRECT PRODUCT ADMINISTRATION DURATION 109 0.0050
689 HAEMATEMESIS 127 0.0050
690 NASAL CONGESTION 294 0.0050
691 COLD SWEAT 88 0.0050
692 END STAGE RENAL DISEASE 91 0.0050
693 CHEST DISCOMFORT 509 0.0050
694 HERNIA 96 0.0050
695 RASH PRURITIC 268 0.0049
696 POLLAKIURIA 206 0.0049
697 HYPOPHAGIA 126 0.0049
698 HYPOXIA 173 0.0049
699 SWOLLEN TONGUE 153 0.0049
700 CAESAREAN SECTION 57 0.0049
701 DRY EYE 244 0.0049
702 DERMATITIS ALLERGIC 61 0.0048
703 PHARYNGITIS 60 0.0048
704 BLOOD PRESSURE FLUCTUATION 116 0.0048
705 TOOTH EXTRACTION 60 0.0048
706 DRUG LEVEL DECREASED 49 0.0048
707 PALLOR 131 0.0048
708 RENAL PAIN 51 0.0048
709 VIRAL INFECTION 160 0.0048
710 DIARRHOEA 3101 0.0048
711 TUBULOINTERSTITIAL NEPHRITIS 90 0.0048
712 TRANSIENT ISCHAEMIC ATTACK 162 0.0048
713 HAEMATOCRIT DECREASED 95 0.0048
714 ORAL CANDIDIASIS 63 0.0048
715 ACUTE RESPIRATORY FAILURE 92 0.0048
716 PRODUCT COMPLAINT 121 0.0048
717 FEELING COLD 132 0.0047
718 HEART RATE IRREGULAR 107 0.0047
719 TOOTH DISORDER 105 0.0047
720 ABDOMINAL DISTENSION 489 0.0047
721 PULMONARY EMBOLISM 445 0.0047
722 CANDIDA INFECTION 79 0.0047
723 OROPHARYNGEAL PAIN 433 0.0047
724 ANGINA PECTORIS 134 0.0047
725 PRODUCT DOSE OMISSION IN ERROR 132 0.0047
726 MUSCULOSKELETAL CHEST PAIN 72 0.0046
727 INCORRECT DOSE ADMINISTERED 1060 0.0046
728 TARDIVE DYSKINESIA 131 0.0046
729 HYPERTHYROIDISM 67 0.0046
730 CELLULITIS 233 0.0046
731 CHOLECYSTITIS 55 0.0046
732 PLATELET COUNT INCREASED 60 0.0046
733 CARDIOMYOPATHY 68 0.0046
734 EXTRA DOSE ADMINISTERED 186 0.0046
735 SKIN DISORDER 153 0.0046
736 BRADYCARDIA 243 0.0046
737 ACUTE RESPIRATORY DISTRESS SYNDROME 81 0.0046
738 CONVULSION 261 0.0046
739 ORAL PAIN 102 0.0046
740 DEEP VEIN THROMBOSIS 296 0.0046
741 SNEEZING 102 0.0045
742 OCULAR DISCOMFORT 51 0.0045
743 RESPIRATORY TRACT CONGESTION 72 0.0045
744 URINARY TRACT INFECTION 771 0.0045
745 APHONIA 63 0.0045
746 DYSPHAGIA 428 0.0045
747 SKIN DISCOLOURATION 206 0.0045
748 POST PROCEDURAL COMPLICATION 86 0.0045
749 PRODUCT DISPENSING ERROR 97 0.0044
750 LEUKOCYTOSIS 80 0.0044
751 HEPATITIS 113 0.0044
752 TENDONITIS 68 0.0044
753 FLUSHING 445 0.0044
754 PRESYNCOPE 106 0.0044
755 SPLENOMEGALY 51 0.0043
756 SPINAL PAIN 51 0.0043
757 EXTRAPYRAMIDAL DISORDER 108 0.0043
758 RED BLOOD CELL COUNT DECREASED 124 0.0043
759 IMMUNE SYSTEM DISORDER 57 0.0043
760 SMALL INTESTINAL OBSTRUCTION 53 0.0043
761 DYSURIA 158 0.0043
762 PNEUMOTHORAX 68 0.0043
763 RESPIRATORY DISTRESS 118 0.0043
764 SYNCOPE 426 0.0043
765 PRURITUS GENERALISED 92 0.0043
766 OXYGEN SATURATION DECREASED 239 0.0042
767 VENTRICULAR TACHYCARDIA 70 0.0042
768 PELVIC PAIN 77 0.0042
769 THROAT IRRITATION 190 0.0042
770 EYE DISORDER 139 0.0042
771 HAEMATOCHEZIA 233 0.0042
772 HOT FLUSH 317 0.0042
773 FAECES DISCOLOURED 91 0.0042
774 PREMATURE BABY 126 0.0042
775 PHOTOSENSITIVITY REACTION 69 0.0042
776 HEPATOTOXICITY 93 0.0042
777 INFLUENZA 465 0.0042
778 DEHYDRATION 556 0.0042
779 PHARYNGEAL OEDEMA 64 0.0042
780 DYSGEUSIA 309 0.0042
781 BONE PAIN 242 0.0041
782 CHROMATURIA 93 0.0041
783 SWELLING FACE 268 0.0041
784 DEAFNESS 107 0.0041
785 FUNGAL INFECTION 136 0.0041
786 DRUG WITHDRAWAL SYNDROME 357 0.0041
787 BLOOD URINE PRESENT 77 0.0041
788 GLAUCOMA 78 0.0040
789 SKIN REACTION 57 0.0040
790 CHILLS 474 0.0040
791 SPINAL FRACTURE 81 0.0040
792 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 287 0.0040
793 MASS 56 0.0040
794 LACRIMATION INCREASED 121 0.0040
795 INFLUENZA LIKE ILLNESS 329 0.0040
796 PRODUCT DOSE OMISSION 260 0.0040
797 GASTROENTERITIS 58 0.0040
798 NERVOUS SYSTEM DISORDER 124 0.0040
799 BLINDNESS UNILATERAL 56 0.0040
800 ORAL DISCOMFORT 55 0.0040
801 BONE DISORDER 72 0.0039
802 DYSPHONIA 231 0.0039
803 PRODUCT DOSE OMISSION ISSUE 1161 0.0039
804 DEVICE ISSUE 354 0.0039
805 CATARACT 235 0.0039
806 EYE PAIN 222 0.0039
807 ABDOMINAL PAIN LOWER 98 0.0039
808 LIP SWELLING 129 0.0039
809 ERECTILE DYSFUNCTION 99 0.0039
810 BLOOD PRESSURE DECREASED 256 0.0038
811 DYSPNOEA EXERTIONAL 145 0.0038
812 COVID-19 675 0.0038
813 EYE SWELLING 143 0.0038
814 EPISTAXIS 286 0.0038
815 COUGH 1071 0.0038
816 ABORTION SPONTANEOUS 153 0.0038
817 DISEASE RECURRENCE 181 0.0038
818 STAPHYLOCOCCAL INFECTION 125 0.0038
819 COLITIS 143 0.0038
820 RHINORRHOEA 243 0.0038
821 BURNING SENSATION 263 0.0037
822 EYE HAEMORRHAGE 50 0.0037
823 BLOOD ALKALINE PHOSPHATASE INCREASED 93 0.0037
824 BLOOD PRESSURE SYSTOLIC INCREASED 73 0.0037
825 MUSCULOSKELETAL DISORDER 71 0.0037
826 DRUG DISPENSING ERROR 57 0.0037
827 UPPER LIMB FRACTURE 74 0.0037
828 PROCEDURAL PAIN 103 0.0037
829 HOSPITALISATION 570 0.0037
830 PARALYSIS 53 0.0037
831 BACTERIAL INFECTION 69 0.0037
832 DIVERTICULITIS 102 0.0037
833 LIVER FUNCTION TEST ABNORMAL 107 0.0037
834 MENORRHAGIA 72 0.0037
835 PHARMACEUTICAL PRODUCT COMPLAINT 95 0.0037
836 FLATULENCE 207 0.0036
837 EMOTIONAL DISTRESS 437 0.0036
838 SKIN LESION 99 0.0036
839 DIABETES MELLITUS 269 0.0035
840 BLOOD UREA INCREASED 59 0.0035
841 LEUKOPENIA 176 0.0035
842 ACUTE KIDNEY INJURY 537 0.0035
843 UPPER GASTROINTESTINAL HAEMORRHAGE 59 0.0035
844 BLOOD SODIUM DECREASED 66 0.0035
845 NEUROPATHY PERIPHERAL 333 0.0035
846 MYALGIA 594 0.0035
847 PULMONARY MASS 52 0.0035
848 HYPERGLYCAEMIA 127 0.0035
849 PRODUCT PRESCRIBING ERROR 83 0.0035
850 AMENORRHOEA 61 0.0035
851 PRODUCTIVE COUGH 166 0.0035
852 THROMBOSIS 278 0.0035
853 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 622 0.0034
854 ABSCESS 55 0.0034
855 LYMPHADENOPATHY 122 0.0034
856 ASPARTATE AMINOTRANSFERASE INCREASED 183 0.0034
857 ATRIAL FIBRILLATION 332 0.0034
858 GOUT 61 0.0034
859 ALANINE AMINOTRANSFERASE INCREASED 208 0.0034
860 DRUG WITHDRAWAL SYNDROME NEONATAL 50 0.0034
861 TOOTH LOSS 70 0.0034
862 HERPES ZOSTER 194 0.0034
863 ACCIDENTAL EXPOSURE TO PRODUCT 345 0.0033
864 HAEMOGLOBIN DECREASED 342 0.0033
865 STEVENS-JOHNSON SYNDROME 74 0.0033
866 DEMENTIA 93 0.0033
867 OSTEOMYELITIS 60 0.0033
868 DEVICE RELATED INFECTION 51 0.0033
869 ERUCTATION 64 0.0033
870 INJECTION SITE REACTION 225 0.0033
871 ECZEMA 171 0.0033
872 PREMATURE DELIVERY 52 0.0033
873 ANAPHYLACTIC REACTION 180 0.0033
874 SKIN ULCER 84 0.0032
875 MOUTH ULCERATION 68 0.0032
876 FRACTURE 61 0.0032
877 HAEMATURIA 110 0.0032
878 RASH GENERALISED 83 0.0032
879 RENAL FAILURE 424 0.0032
880 HEPATIC FAILURE 96 0.0032
881 BLOOD TRIGLYCERIDES INCREASED 56 0.0032
882 GYNAECOMASTIA 98 0.0032
883 CEREBROVASCULAR ACCIDENT 536 0.0032
884 PANCREATITIS ACUTE 71 0.0032
885 ABASIA 78 0.0032
886 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 164 0.0031
887 VAGINAL HAEMORRHAGE 136 0.0031
888 HAEMATOMA 81 0.0031
889 LOCALISED INFECTION 75 0.0031
890 VISUAL ACUITY REDUCED 103 0.0031
891 CLOSTRIDIUM DIFFICILE INFECTION 67 0.0031
892 CEREBRAL HAEMORRHAGE 109 0.0030
893 LOCAL SWELLING 53 0.0030
894 RASH MACULAR 106 0.0030
895 TRANSAMINASES INCREASED 67 0.0030
896 HYPOGLYCAEMIA 145 0.0030
897 PSORIASIS 390 0.0030
898 RESPIRATORY FAILURE 217 0.0030
899 HAEMOPTYSIS 83 0.0030
900 SKIN FISSURES 58 0.0030
901 HYPONATRAEMIA 165 0.0029
902 THROMBOCYTOPENIA 327 0.0029
903 HIP FRACTURE 94 0.0029
904 DERMATITIS 61 0.0029
905 CONJUNCTIVITIS 53 0.0029
906 ANAEMIA 543 0.0028
907 PERICARDIAL EFFUSION 65 0.0028
908 PRODUCT PRESCRIBING ISSUE 61 0.0028
909 CEREBRAL INFARCTION 68 0.0028
910 CORONARY ARTERY DISEASE 84 0.0028
911 DERMATITIS ATOPIC 145 0.0027
912 BLINDNESS 112 0.0027
913 INTESTINAL OBSTRUCTION 103 0.0027
914 INJECTION SITE URTICARIA 67 0.0027
915 MULTIPLE ORGAN DYSFUNCTION SYNDROME 77 0.0027
916 HAEMORRHAGE 283 0.0027
917 SEPSIS 301 0.0027
918 SHOCK 62 0.0027
919 HYPOACUSIS 116 0.0027
920 SKIN IRRITATION 123 0.0027
921 RASH PAPULAR 60 0.0027
922 CARDIAC DISORDER 249 0.0027
923 RASH ERYTHEMATOUS 127 0.0027
924 EYE PRURITUS 89 0.0026
925 FEMUR FRACTURE 82 0.0026
926 WHITE BLOOD CELL COUNT DECREASED 285 0.0026
927 ERYTHEMA 538 0.0026
928 MYOCARDIAL INFARCTION 456 0.0026
929 ACNE 198 0.0026
930 RENAL INJURY 77 0.0026
931 OCULAR HYPERAEMIA 123 0.0026
932 PLEURAL EFFUSION 157 0.0026
933 FEBRILE NEUTROPENIA 171 0.0026
934 PNEUMONITIS 70 0.0026
935 AGEUSIA 64 0.0026
936 DRUG EXPOSURE DURING PREGNANCY 86 0.0025
937 CARDIOVASCULAR DISORDER 64 0.0025
938 RENAL DISORDER 116 0.0025
939 DEPENDENCE 136 0.0025
940 BLOOD CREATININE INCREASED 161 0.0025
941 PRODUCT PREPARATION ERROR 50 0.0024
942 INJECTION SITE BRUISING 194 0.0024
943 ANGIOEDEMA 107 0.0024
944 EYE IRRITATION 139 0.0024
945 SKIN EXFOLIATION 203 0.0024
946 BONE DENSITY DECREASED 75 0.0024
947 MENSTRUATION IRREGULAR 63 0.0023
948 GASTROINTESTINAL HAEMORRHAGE 196 0.0023
949 INJECTION SITE PRURITUS 152 0.0023
950 INCORRECT ROUTE OF DRUG ADMINISTRATION 81 0.0023
951 PLATELET COUNT DECREASED 238 0.0022
952 BLOOD GLUCOSE DECREASED 106 0.0022
953 LACTIC ACIDOSIS 71 0.0022
954 ASCITES 64 0.0022
955 INJECTION SITE PAIN 667 0.0022
956 DEVICE DISLOCATION 93 0.0021
957 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 72 0.0021
958 CARDIAC FAILURE 169 0.0021
959 DRY SKIN 281 0.0021
960 RENAL IMPAIRMENT 175 0.0021
961 THERAPY INTERRUPTED 146 0.0020
962 PAIN OF SKIN 55 0.0020
963 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 51 0.0020
964 PRODUCT STORAGE ERROR 173 0.0020
965 JAUNDICE 53 0.0020
966 ANAPHYLACTIC SHOCK 50 0.0019
967 HEPATIC FUNCTION ABNORMAL 72 0.0019
968 INJECTION SITE RASH 59 0.0019
969 INJECTION SITE MASS 71 0.0019
970 RENAL FAILURE ACUTE 81 0.0019
971 INTERNATIONAL NORMALISED RATIO INCREASED 53 0.0019
972 INJECTION SITE SWELLING 142 0.0019
973 INJECTION SITE ERYTHEMA 226 0.0018
974 INJECTION SITE HAEMORRHAGE 143 0.0018
975 CARDIAC FAILURE CONGESTIVE 140 0.0017
976 BREAST CANCER 161 0.0017
977 HYPERKALAEMIA 60 0.0017
978 DEATH 1467 0.0017
979 NEUTROPHIL COUNT DECREASED 69 0.0017
980 SEPTIC SHOCK 71 0.0016
981 NEUTROPENIA 216 0.0016
982 BLOOD GLUCOSE INCREASED 292 0.0015
983 SKIN BURNING SENSATION 103 0.0014
984 PANCYTOPENIA 80 0.0014
985 DRUG DOSE OMISSION BY DEVICE 102 0.0013
986 DEVICE MALFUNCTION 91 0.0013
987 DISEASE PROGRESSION 152 0.0013
988 DEVICE LEAKAGE 55 0.0013
989 NEOPLASM MALIGNANT 84 0.0013
990 MALIGNANT NEOPLASM PROGRESSION 113 0.0011